Author

A. Heider

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

A. Beshirova· 1 shared A. Buck· 1 shared A. Gerber· 1 shared B. Schweiger· 1 shared B. Snijder· 1 shared D. Kaymak· 1 shared E. M. Bartoszek· 1 shared G. Hutter· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Beshirova

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increase of permissive secondary antiviral mutations in the evolution of A(H1N1)pdm09 influenza virus neuraminidases

S. C. Duwe, J. Milde, A. Heider, M. Wedde, B. Schweiger, R. Duerrwald

The paper identifies permissive secondary mutations in A(H1N1)pdm09 influenza virus neuraminidases that increase antiviral resistance and highlights their increasing prevalence over time.

bioRxiv · Jun 18, 2024 · PreprintMicrobiology

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

T. A. Martins, N. Tatari, D. Kaymak, S. Hogan, E. M. Bartoszek, R. Wieboldt, M.-F. Ritz, A. Buck, M. McDaid, A. Gerber, A. Beshirova, M. M. Etter, A. Heider, T. Shekarian, H. Mohamed, , G. Hutter

This paper develops a CAR T cell therapy that secretes a CD47 blocker to enhance anti-EGFRvIII efficacy against glioblastoma by modulating the tumor microenvironment.

bioRxiv · Aug 31, 2023Cancer Biology